Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences Subscribe to our YouTube channel for the latest MadeAi product updates
Login
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

112 articles published Follow:
MadeAi | Beyond Real-World Data: Synthetic Data in Evidence Generation

Beyond Real-World Data: Synthetic Data in Evidence Generation

White PaperAugust 28, 202670Views0Likes0Comments
Evidence generation increasingly depends on real-world data, but access delays, sparse populations, limited comparators, and privacy constraints can leave critical evidence questions unanswered. Synthetic data offers a way to reduce these barriers by creating statistically representative datasets that support faster analysis, testing, collaboration, and bias assessment. Its value, however, depends on rigorous validation, clear governance,…

Read More

AI-Powered Evidence Generation Using Real-World Data

AI-Powered Evidence Generation Using Real-World Data

BlogAugust 20, 202670Views0Likes0Comments
Overview Real-World Data (RWD) to Real-World Evidence (RWE) conversion stands at the center of modern life-sciences decision-making. Randomized controlled trials remain essential for establishing causality under controlled conditions, yet they leave gaps in understanding how treatments perform across diverse patients, care settings, and longer time horizons. RWD, drawn from electronic health records, claims, registries, wearables,…

Read More

MadeAi Wins Gold Stevie Award

MadeAi™ Wins Gold Stevie® Award in 2026 International Business Awards®

MadeAi Press ReleaseAugust 19, 202697Views0Likes0Comments
Newest version of MadeAi™ hailed by judges as “an impressive application of governed AI to a complex and highly regulated life-sciences workflow”  Cambridge, MA, August 19, 2026—MadeAi™, a purpose-built AI platform for evidence synthesis in regulated life sciences, announced that its updated platform was a winner of a Gold Stevie® Award in The 23rd Annual…

Read More